The Impact of a Colonoscopy Monitoring Program on Endoscopists' Performance
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Aug 28, 2024
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how a colonoscopy monitoring program can help doctors, called endoscopists, find more growths called adenomas during colonoscopy procedures. Adenomas are a type of polyp that can sometimes turn into cancer, so finding them early is important. The study will also explore how this program might affect the detection of other types of lesions, including sessile serrated adenomas, which are another kind of polyp that can also be concerning.
To participate, doctors must have at least one year of experience performing colonoscopies. Those involved in the trial will receive updates on their performance every three months for a year. This feedback aims to help improve their skills in detecting these important growths. The study is currently not recruiting participants, but it will eventually include all qualified endoscopists regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Endoscopists with at least 1 year of colonoscopy experience
- Exclusion Criteria:
- • Endoscopists with less than 1 year of colonoscopy experience
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported